Skip to main content

Advertisement

Log in

What to Know About Biopsy Sampling and Pathology in Vasculitis?

  • Vasculitis (C Dejaco and C Duftner, Section Editors)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To summarize the histologic findings of vasculitis, and to give some practical considerations on biopsy samples.

Recent Findings

The larger use of imaging and the discoveries of serological markers in the diagnosis of vasculitis have increased the clinical recognition of these entities. Nevertheless, biopsy remains the gold standard for diagnosis in most cases. So far, biopsies are also useful to obtain information about prognosis and to guide a more specific treatment. In recent years, less invasive diagnostic approaches have become available, lowering the risks related to the procedure and permitting a definite diagnosis in most cases.

Summary

Histological examination permits a definite diagnosis of vasculitis. However, the findings may be nonspecific if not evaluated in the proper clinical setting. The interaction between clinicians and pathologists is crucial to obtain a definite diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/23045170/.

    Article  CAS  Google Scholar 

  2. Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ. Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum. 2015;44:724–8 [cited 2017 Jan 15]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0049017215000062.

    Article  Google Scholar 

  3. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.

    Article  CAS  Google Scholar 

  4. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34 [cited 2018 Apr 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1975175.

    Article  CAS  Google Scholar 

  5. Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology. 2015;54:463–70 [cited 2014 Nov 22]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25193809.

    Article  Google Scholar 

  6. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. 2017;56:506–15 [cited 2017 Nov 11]. Available from: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kew273.

    CAS  PubMed  Google Scholar 

  7. •• Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis [Internet] BMJ Publishing Group. 2020;79:19–130 [cited 2020 Mar 30]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31270110Latest EULAR recommendations for the management of large vessel vasculitis.

    Article  Google Scholar 

  8. •• Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 2021;73:1349–1365 [cited 2022 Jan 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/34235884/Latest ACR/VF guideline for the management of large vessel vasculitis.

  9. Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of Giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20:1–270 [cited 2022 May 27]. Available from: https://pubmed.ncbi.nlm.nih.gov/27925577/.

    Article  Google Scholar 

  10. Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology. 2020;59:1011–20 [cited 2022 Jan 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/31529073/.

    Article  Google Scholar 

  11. • Muratore F, Boiardi L, Cavazza A, Tiengo G, Galli E, Aldigeri R, et al. Association between specimen length and number of sections and diagnostic yield of temporal artery biopsy for giant cell arteritis. Arthritis Care Res 2021;73:402–408 [cited 2022 Jul 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32741116/Authors investigated the association between specimen length and number of sections evaluated and the diagnostic yield of TAB for GCA. A postfixation TAB specimen length of at least 5 mm is sufficient to make a histologic diagnosis of GCA. In order not to miss inflammatory changes, at least 3 further sections at deeper levels should be evaluated in all negative TAB specimens.

  12. Germanò G, Muratore F, Cimino L, Lo Gullo A, Possemato N, Macchioni P, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology 2014;54:400–404 [cited 2014 Nov 22]. Available from: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keu241

  13. Banz Y, Stone JH. Why do temporal arteries go wrong? Principles and pearls from a clinician and a pathologist. Rheumatology; 2018;57:ii3–i10 [cited 2022 Jan 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/29982782/

  14. Mahr A, Saba M, Kambouchner M, Polivka M, Baudrimont M, Brochériou I, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826–8 [cited 2020 Mar 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16699053.

    Article  CAS  Google Scholar 

  15. Chakrabarty A, Franks AJ. Temporal artery biopsy: is there any value in examining biopsies at multiple levels? J Clin Pathol. 2000;53:131–6.

    Article  CAS  Google Scholar 

  16. Niederkohr RD, Levin LA. Management of the patient with suspected temporal arteritis a decision-analytic approach. Ophthalmology. 2005;112:744–56 [cited 2022 Jan 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/15878052/.

    Article  Google Scholar 

  17. Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987–92 [cited 2014 Dec 22]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8185147.

    Article  CAS  Google Scholar 

  18. Narváez J, Bernad B, Roig-Vilaseca D, García-Gómez C, Gómez-Vaquero C, Juanola X, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37:13–9 [cited 2014 Dec 8]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17360027.

    Article  Google Scholar 

  19. Bury D, Joseph J, Dawson TP. Does preoperative steroid treatment affect the histology in giant cell (cranial) arteritis? J Clin Pathol. 2012;65:1138–40 [cited 2014 Dec 22]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22844066.

    Article  Google Scholar 

  20. Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, et al. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol. 2017;30:788–96 [cited 2022 Jul 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/28256573/.

    Article  CAS  Google Scholar 

  21. • Cavazza A, Muratore F, Boiardi L, Restuccia G, Pipitone N, Pazzola G, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol. 2014;38:1360–1370 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/25216320/Revision of the largest cohort of temporal artery biopsies performed for suspected temporal arteritis. Authors provide a detailed histologic description and correlate the histology with the clinical findings.

  22. Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, et al. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis. J Autoimmun. 2016;69:94–101 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/27009904/.

    Article  Google Scholar 

  23. Delaval L, Samson M, Schein F, Agard C, Tréfond L, Deroux A, et al. Temporal arteritis revealing antineutrophil cytoplasmic antibody-associated vasculitides: a case-control study. Arthritis Rheumatol. 2021;73:286–94 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32951354/.

    Article  CAS  Google Scholar 

  24. •• Chung SA, Gorelik M, Langford CA, Maz M, Abril A, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the Management of Polyarteritis Nodosa. Arthritis Rheumatol [Internet] John Wiley and Sons Inc. 2021;73:1384–1393 [cited 2022 Jan 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34235883The new ACR/VF guidelines for the management of polyarteritis nodosa.

  25. Hernández-Rodrígueza J, Hoffmanb GS. Updating single-organ vasculitis. Curr Opin Rheumatol. 2012;24:38–45 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/22089096/.

    Article  Google Scholar 

  26. Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis study group database. Arthritis Rheum. 2010;62:616–26 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/20112401/.

    Article  Google Scholar 

  27. Vital C, Vital A, Canron MH, Jaffré A, Viallard JF, Ragnaud JM, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006;11:20–9 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/16519779/.

    Article  Google Scholar 

  28. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus [internet]. Lupus. 1998;7:238–58 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/9643314/.

    Article  CAS  Google Scholar 

  29. Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa. I. a literature-based decision analysis approach. Arthritis Rheum. 1988;31:1117–27 [cited 2022 Jan 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/2901840/.

    Article  CAS  Google Scholar 

  30. Hilton DA, Jacob J, Househam L. Complications following sural and peroneal nerve biopsies. J Neurol Neurosurg Psychiatry. 2007;78:1271–2 [cited 2022 May 9]. Available from: www.jnnp.com.

    Article  Google Scholar 

  31. Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56:3–23 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/20055902/.

    Article  Google Scholar 

  32. Forbess L, Bannykh S. Polyarteritis nodosa. Rheum Dis Clin N Am. 2015;41:33–46 [cited 2022 Jan 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/25399938/.

    Article  Google Scholar 

  33. Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis study group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis. 2017;76:647–53 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/27481830/.

    Article  CAS  Google Scholar 

  34. Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81:315–20 [cited 2022 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/35110333/.

    Article  Google Scholar 

  35. Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. 2022 American College of Rheumatology/European Alliance of associations for rheumatology classification criteria for microscopic Polyangiitis. Arthritis Rheumatol. 2022;74:400–6 [cited 2022 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/35106973/.

    Article  CAS  Google Scholar 

  36. Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of associations for rheumatology classification criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis. 2022;81:309–14 [cited 2022 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/35110334/.

  37. Jayne D. Vasculitis-when can biopsy be avoided? Nephrol Dial Transplant. 2017;32:1454–6 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/29059405/.

  38. Chapman GB, Farrah TE, Chapman FA, Pugh D, Bellamy COC, Lahiri R, et al. Utility of interval kidney biopsy in ANCA-associated vasculitis. Rheumatology. 2022;61 [cited 2022 May 10]. Available from: https://pubmed.ncbi.nlm.nih.gov/34505902/.

  39. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/20616173/.

  40. Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL. Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J. 1997;10:2738–43 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/9493653/.

  41. Daum TE, Specks U, Colby TV, Edell ES, Brutinel MW, UBS P, et al. Tracheobronchial involvement in Wegener’s granulomatosis. Am J Respir Crit Care Med. 1995;151:522–6 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/7842215/.

  42. Rodrigues AJ, Jacomelli M, Baldow RX, Barbas CV, Figueiredo VR. Laryngeal and tracheobronchial involvement in Wegener’s granulomatosis. Rev Bras Reumatol. 2012;52:227–35 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/22460412/.

  43. Yamakawa H, Oda T, Baba T, Ogura T. Pleuroparenchymal fibroelastosis with positive MPO-ANCA diagnosed with a CT-guided percutaneous needle biopsy. BMJ Case Rep. 2018;2018 [cited 2022 May 13]. Available from: https://pubmed.ncbi.nlm.nih.gov/29478005/.

  44. Hesford J, Andrew A, Medford RL, Gunawardena H. Lessons of the month: ANCA-associated vasculitis-granulomatosis with polyangiitis: “the great mimic” case presentation. Clinical Medicine. 2021;21:231–4 [cited 2022 May 13]. Available from: www.linkedin.com/in/andrew-medford-.

  45. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener’s granulomatosis: review of 87 open lung biopsies from 67 patients. Am J Surg Pathol. 1991;15:315–33.

    Article  CAS  Google Scholar 

  46. Jennings CR, Jones NS, Dugar J, Powell RJ, Lowe J. Wegener’s granulomatosis-a review of diagnosis and treatment in 53 subjects*. Rhinology. 1998;36:188–91.

    CAS  PubMed  Google Scholar 

  47. Devaney KO, Travis WD, Hoffman G, Leavitt R, Lebovics R, Fauci AS. Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990;14:555–64.

    Article  CAS  Google Scholar 

  48. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society research committee. QJM: An International Journal of Medicine [Internet] Oxford Academic. 1992;83:427–38 [cited 2022 Jan 19]. Available from: https://academic.oup.com/qjmed/article/83/3/427/1555478.

  49. Raynaud P, Garrel R, Rigau V, Poizat F, Vic P, Cartier C, et al. How can the diagnostic value of head and neck biopsies be increased in Wegener’s granulomatosis: a clinicopathologic study of 49 biopsies in 21 patients. Ann Pathol. 2005;25:87–93 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/16142159/.

  50. Borner U, Landis BN, Banz Y, Villiger P, Ballinari P, Caversaccio M, et al. Diagnostic value of biopsies in identifying cytoplasmic antineutrophil cytoplasmic antibody-negative localized Wegener’s granulomatosis presenting primarily with sinonasal disease. Am J Rhinol AllergyI. 2012;26:475–80 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/23232198/.

  51. • Beltrán Rodríguez-Cabo O, Reyes E, Rojas-Serrano J, Flores-Suárez LF. Increased histopathological yield for granulomatosis with polyangiitis based on nasal endoscopy of suspected active lesions. Eur Arch Otorhinolaryngol 2018;275:425–9 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/29230559/In this study, the authors found that the endoscopic nasal observation and the biopsy on the precise lesion increased the diagnostic yield in the nasal muscosa. In particular, polypoid nodules, persistent white submucosal nodules, and bloody submucosal patches had the better diagnostic performance.

  52. McDonald TJ, DeRemee RA. Head and neck involvement in Wegener’s granulomatosis (WG). Adv Exp med biol [internet]. Adv Exp Med Biol. 1993;336:309–13 [cited 2022 Jul 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/8296624/.

  53. • Lacou M, Leroy M, le Lan N, Toquet C, Espitia-Thibault A, Graveleau J, et al. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count. Rheumatology 2021;60:699–707 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32789447/In this retrospective study, the authors examined the diagnostic yield of muscle biopsy in the diagnosis of AAVs. They found a good specificity and sensitivity and no adverse events. They concluded that muscle biopsy cold be a diagnostic tool in non-renal vasculitis.

  54. Colby TV, Tazelaar HD, Specks U, RA DR. Nasal biopsy in Wegener’s granulomatosis. Hum Pathol. 1991;22:101–4 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/2001871/.

  55. Mark EJ, Matsubara O, Tan-Liu NS, Fienberg R. The pulmonary biopsy in the early diagnosis of Wegener’s (pathergic) granulomatosis: a study based on 35 open lung biopsies. Hum Pathol. 1988;19:1065–71.

    Article  CAS  Google Scholar 

  56. Katzenstein ALA. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol. 2000;114:767–72 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/11068552/.

  57. Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, et al. Nomenclature of cutaneous Vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheumatol. 2018;70:171–84 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/29136340/.

  58. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27:504–28. [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/16314707/.

  59. Mimouni D, Ng PP, Rencic A, Nikolskaia O, v., Bernstein BD, Nousari HC. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol. 2003;148:789–94 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/12752140/.

  60. Furukawa F. Cutaneous polyarteritis nodosa: an update. Ann Vasc Dis. 2012;5:282–8 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/23555526/.

  61. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9:71–92 [cited 2022 Jan 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/18284262/.

  62. Sais G, Vidaller A, Jucglà A, Servitje O, Condom E, Peyrí J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998;134:309–15 [cited 2022 Jan 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/9521029/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Muratore.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marvisi, C., Muratore, F., Cabassi, C. et al. What to Know About Biopsy Sampling and Pathology in Vasculitis?. Curr Rheumatol Rep 24, 279–291 (2022). https://doi.org/10.1007/s11926-022-01082-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-022-01082-6

Keywords

Navigation